Correlation Between Arrow Electronics and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Arrow Electronics and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrow Electronics and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrow Electronics and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Arrow Electronics and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrow Electronics with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrow Electronics and Tarsus Pharmaceuticals.
Diversification Opportunities for Arrow Electronics and Tarsus Pharmaceuticals
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Arrow and Tarsus is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Arrow Electronics and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Arrow Electronics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrow Electronics are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Arrow Electronics i.e., Arrow Electronics and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Arrow Electronics and Tarsus Pharmaceuticals
Considering the 90-day investment horizon Arrow Electronics is expected to generate 8.06 times less return on investment than Tarsus Pharmaceuticals. But when comparing it to its historical volatility, Arrow Electronics is 2.39 times less risky than Tarsus Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1,587 in Tarsus Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 3,379 from holding Tarsus Pharmaceuticals or generate 212.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Arrow Electronics vs. Tarsus Pharmaceuticals
Performance |
Timeline |
Arrow Electronics |
Tarsus Pharmaceuticals |
Arrow Electronics and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arrow Electronics and Tarsus Pharmaceuticals
The main advantage of trading using opposite Arrow Electronics and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrow Electronics position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.Arrow Electronics vs. Insight Enterprises | Arrow Electronics vs. Synnex | Arrow Electronics vs. Climb Global Solutions | Arrow Electronics vs. ScanSource |
Tarsus Pharmaceuticals vs. Capricor Therapeutics | Tarsus Pharmaceuticals vs. Soleno Therapeutics | Tarsus Pharmaceuticals vs. Bio Path Holdings | Tarsus Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |